Your browser doesn't support javascript.
loading
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
Ribas, Antoni; Hamid, Omid; Daud, Adil; Hodi, F Stephen; Wolchok, Jedd D; Kefford, Richard; Joshua, Anthony M; Patnaik, Amita; Hwu, Wen-Jen; Weber, Jeffrey S; Gangadhar, Tara C; Hersey, Peter; Dronca, Roxana; Joseph, Richard W; Zarour, Hassane; Chmielowski, Bartosz; Lawrence, Donald P; Algazi, Alain; Rizvi, Naiyer A; Hoffner, Brianna; Mateus, Christine; Gergich, Kevin; Lindia, Jill A; Giannotti, Maxine; Li, Xiaoyun Nicole; Ebbinghaus, Scot; Kang, S Peter; Robert, Caroline.
Afiliação
  • Ribas A; Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles.
  • Hamid O; Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California.
  • Daud A; Department of Hematology/Oncology, University of California-San Francisco, San Francisco.
  • Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Kefford R; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia.
  • Joshua AM; Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
  • Patnaik A; Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio.
  • Hwu WJ; Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston.
  • Weber JS; Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida.
  • Gangadhar TC; Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia.
  • Hersey P; Department of Medicine, University of Sydney, Sydney, Australia.
  • Dronca R; Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota.
  • Joseph RW; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida.
  • Zarour H; Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Chmielowski B; Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles.
  • Lawrence DP; Department of Hematology/Oncology, Massachusetts General Hospital, Boston.
  • Algazi A; Department of Hematology/Oncology, University of California-San Francisco, San Francisco.
  • Rizvi NA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Hoffner B; Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California.
  • Mateus C; Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France.
  • Gergich K; Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey.
  • Lindia JA; Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey.
  • Giannotti M; Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey.
  • Li XN; BARDS, Merck & Co, Inc, Kenilworth, New Jersey.
  • Ebbinghaus S; Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey.
  • Kang SP; Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey.
  • Robert C; Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France.
JAMA ; 315(15): 1600-9, 2016 Apr 19.
Article em En | MEDLINE | ID: mdl-27092830
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Anticorpos Monoclonais Humanizados / Melanoma / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Anticorpos Monoclonais Humanizados / Melanoma / Antineoplásicos Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2016 Tipo de documento: Article